Cart
sales@molnova.com
HX 531
CAS No. 188844-34-0
HX 531( —— )
Catalog No. M27636 CAS No. 188844-34-0
HX 531 is a potent antagonist of the retinoid X receptor with an IC50 value of 18 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 257 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHX 531
-
NoteResearch use only, not for human use.
-
Brief DescriptionHX 531 is a potent antagonist of the retinoid X receptor with an IC50 value of 18 nM.
-
DescriptionHX 531 is a potent antagonist of the retinoid X receptor with an IC50 value of 18 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetRetinoid Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number188844-34-0
-
Formula Weight483.568
-
Molecular FormulaC29H29N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (68.93 mM)
-
SMILESCN1c2ccc(cc2N=C(c2ccc(cc2)C(O)=O)c2cc3c(cc12)C(C)(C)CCC3(C)C)N(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Barbosa V, et al. Effects of steaming on contaminants of emerging concern levels in seafood. Food Chem Toxicol. 2018 Aug;118:490-504.
molnova catalog
related products
-
MM 11253
MM 11253 is a RARγ antagonist with IC50 of 44nM.
-
CD 1530
CD 1530 is a selective and potent RARγ agonist (Kd:150 nM) with potential anticancer activity, shows insecticidal activity against Cryptobacterium hidradii nematodes, and can be used to study oral carcinogenesis.
-
BMS493
BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.
